Search
for
Sort by
Research 151–180 of 1000+
- A Case of Hair Change and Acneiform Eruption Induced by ZD1839 (Iressa$^{(R)}$)
- Non-small cell lung carcinoma spheroid models in agarose microwells for drug response studies
- Molecular Targeted Agents and Biologic Therapies for Non-small Cell Lung Cancer
- Sorting Out the Seeming Increase in Lung Cancer in Women Who Have Never Smoked
- Amphiregulin in Fibrotic Diseases and Cancer
- PC-SPES Studies Promising, But Manufacturer Shuts Down
- Syntaxin 9 is Enriched in Skin Hair Follicle Epithelium and Interacts With the Epidermal Growth Factor Receptor
- Malignant epithelial tumors: Part II. Therapy and prevention
- Lady with Long Eyelashes…!
- A Case of Inflammatory Nonscarring Alopecia Associated With the Tyrosine Kinase Inhibitor Nilotinib
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- The urine as a diagnostic key for a homozygous EGFR mutation
- Hydroxychloroquine modulates the progression of experimentally induced benign prostatic hyperplasia in rats via targeting EGFR/ERK/STAT3 and AR/FOXO1/TRAIL pathways: computational and in vivo studies
- Phase I Study of the Hedgehog Pathway Inhibitor IPI-926 in Adult Patients with Solid Tumors
- Analysis of Data From Breast Diseases Treated With 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia
- Novel small molecules downregulate CDK1 expression and inhibit Wnt/β-catenin signaling in cutaneous squamous cell carcinoma by targeting its distinct tumor-specific cellular landscape
- Abstract 1219: Defective catagen entry in EGFR deficient skin precedes cutaneous inflammation
- The patient outcomes with EGFR-mutated advanced non-small-cell lung cancer receiving aumolertinib as first-line treatment.
- Abstract 18: Targeted epidermal ablation of EGFR causes local and systemic inflammation
- 129 Targeted inhibition of EGFR reduces anti-microbial defense mechanisms at the hair canal
- Regulation of Semaphorin3A in the process of cutaneous wound healing
- 870 Y27632 promotes proliferation via EGFR signaling in a newly isolated and characterized human primary sebocyte cell line
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- LPA-producing enzyme PA-PLA<sub>1</sub>α regulates hair follicle development by modulating EGFR signalling
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Hair eruption initiates and commensal skin microbiota aggravate adverse events of anti-EGFR therapy
- Immune cell regulation of the hair cycle
- Depletion of <i>Gsdma1/2/3</i> alleviates PMA-induced epidermal hyperplasia by inhibiting the EGFR–Stat3/Akt pathway
- Piperonylic Acid Promotes Hair Growth by Activation of EGFR and Wnt/β-Catenin Pathway
- Enzyme Inhibitors from Gorgonians and Soft Corals